IRS1 and Insulin resistance: β-arrestin 1 can alter insulin signaling by inhibiting insulin-induced proteasomal degradation of IRS-1 and the inhibition of beta-arrestin-1 leads to enhanced IRS-1 degradation and accentuated cellular insulin resistance [148].